Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc. logo
NBIX

Neurocrine Biosciences Inc. (NBIX)

$108.290.04%

Market is closed
– opens on 8 PM, 31 Jan 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$107.74
Day's Range
$109.295
$73.13
52-Week Range
$129.29
1 month return9.85%
3 month return5.97%
1 year return36.99%
5 year return26.65%

Analyst Recommendation

based on 34 analysts ratings

Buy
61%
Buy
35%
Hold
2%
Sell

Based on 34 Wall street analysts offering stock ratings for Neurocrine Biosciences Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 18.09%

Current

$108.29

Target

$127.88

Recommendation Trend

Based on 34 analyst

Current1M Ago3M Ago
Buy
21
22
21
Hold
12
11
11
Sell
1
1
1
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization10.4B
Book Value$16.07
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)0.6
PE Ratio180.42
PEG Ratio1.87
Wall Street Target Price127.88

Valuation

Trailing PE180.42
Forward PE28.82
Price/Book (mrq)7.3
Enterprise Value10.7B
Enterprise Value/Revenue7.73
Enterprise Value/Ebitda98.51

Technicals

Beta0.52
50 Day MA117.27
200 Day MA104.57

Institutional Holdings

BlackRock Inc

12.53%

Vanguard Group Inc

9.36%

HHG PLC

5.12%

State Street Corporation

3.92%

Bellevue Group AG

2.97%

JPMorgan Chase & Co

2.47%

Company Information

Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.
OrganizationNeurocrine Biosciences Inc.
Employees1150
CEODr. Kevin C. Gorman Ph.D.
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Neurocrine Biosciences Inc. share price today?

Can Indians buy Neurocrine Biosciences Inc. shares?

How can I buy Neurocrine Biosciences Inc. shares from India?

Can Fractional shares of Neurocrine Biosciences Inc. be purchased?

What are the documents required to start investing in Neurocrine Biosciences Inc. stocks?

What are today’s High and Low prices of Neurocrine Biosciences Inc.?

What are today’s traded volumes of Neurocrine Biosciences Inc.?

What is today’s market capitalisation of Neurocrine Biosciences Inc.?

What is the 52 Week High and Low Range of Neurocrine Biosciences Inc.?

How much percentage Neurocrine Biosciences Inc. is down from its 52 Week High?

How much percentage Neurocrine Biosciences Inc. is up from its 52 Week low?

What are the historical returns of Neurocrine Biosciences Inc.?

Who is the Chief Executive Officer (CEO) of Neurocrine Biosciences Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*